Sublingual Microcirculation in Children With Compensated T1D Using the SDF Method

Sponsor
Vlasta Krausová (Other)
Overall Status
Recruiting
CT.gov ID
NCT05958264
Collaborator
(none)
40
1
12
3.3

Study Details

Study Description

Brief Summary

The main goal of the study is to describe the sublingual microcirculation of children with type 1 diabetes mellitus (T1D) with stable and satisfactory treatment of the disease and to compare it with previously measured parameters of healthy children, NCT05324228.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    After recording the basic anthropometric parameters, pressure and pulse, each child who meets the inclusion criteria will have their microcirculation measured using a Sidestream Dark-Field (SDF) probe placed sublingually by one examiner using the SDF method. The measurement will be performed in supine position in a disease-free period, with normal diets, at least 2 hours after the last meal, for girls outside the menses period. Premedication or analgesia will not be used. A total of 3 video clips will be recorded from different parts of the sublingual area with a minimum length of 20 seconds in a row, unless the child needs a short break between measurements. The recorded videos will then be processed offline by one evaluator who is trained and experienced in microcirculation evaluation, three best and most stable parts of each video clip will be analysed.

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    40 participants
    Observational Model:
    Case-Only
    Time Perspective:
    Prospective
    Official Title:
    Evaluation of Sublingual Microcirculation Using Sidestream Dark-Field Imaging in Children With Type 1 Diabetes Mellitus With Favorable Treatment Outcomes.
    Actual Study Start Date :
    Feb 1, 2023
    Anticipated Primary Completion Date :
    Dec 1, 2023
    Anticipated Study Completion Date :
    Feb 1, 2024

    Arms and Interventions

    Arm Intervention/Treatment
    Preschool children

    10 preschool children with T1D aged 3-5,9 years.

    Children of younger school age

    10 children of younger school age aged 6-10,9 years with T1D.

    Children in puberty

    10 children in puberty aged 11-14,9 years with T1D

    Postpubertal adolescents

    10 postpubertal adolescents aged 15-18,9 years with T1D

    Outcome Measures

    Primary Outcome Measures

    1. Determination of Total Vascular Density of sublingual microcirculation of children with T1D [baseline]

      Total length of vessels divided by total surface of area

    2. Determination of Microvascular Flow Index (MFI) of sublingual microcirculation of children with T1D [baseline]

      The image is divided into four quadrants and the predominant type of flow (absent = 0, intermittent = 1, sluggish = 2, normal = 3, and hyperdynamic = 4) is assessed in each quadrant. The MFI score represents the averaged values of the four. A 20 μm cut-off is used to separate small vessels (mostly capillaries) from large vessels (mostly venules).

    3. Determination of Small Vessel Density of sublingual microcirculation of children with T1D [baseline]

      Total length of small vessels divided by total surface of area. A 20 μm cut-off is used to separate small vessels (mostly capillaries) from large vessels (mostly venules).

    4. Determination of Proportion of Perfused Vessels (all) of sublingual microcirculation of children with T1D [baselina]

      The proportion of perfused vessels (PPV [%]) can be calculated as follows: 100 × (total number of vessels - [no flow + intermittent flow])/total number of vessels.

    5. Determination of Proportion of Perfused Small Vessels (PPSV) of sublingual microcirculation of children with T1D [baseline]

      The proportion of perfused small vessels (PPSV [%]) can be calculated as follows: 100 × (total number of small vessels - [no flow + intermittent flow])/total number of small vessels. A 20 μm cut-off is used to separate small vessels (mostly capillaries) from large vessels (mostly venules).

    6. Determination of Perfused Vessel Density (PVD) of sublingual microcirculation of children with T1D [baseline]

      Total length of vessels - (no flow + intermittent flow) divided by total surface of area

    7. Determination of Perfused Small Vessel Density (PSVD) of sublingual microcirculation of children with T1D [baseline]

      Total length of small vessels - (small vessels with no flow + intermittent flow) divided by total surface of area. A 20 μm cut-off is used to separate small vessels (mostly capillaries) from large vessels (mostly venules).

    8. Determination of DeBacker Score of sublingual microcirculation of children [baseline]

      In this score, three equidistant horizontal and three equidistant vertical lines are drawn on the screen. Vessel density can be calculated as the number of vessels crossing the lines divided by the total length of the lines.

    Secondary Outcome Measures

    1. Differences in Total Vascular Density of sublingual microcirculation in different age and gender categories in children with T1D [baseline]

      Comparison in children aged 3-5,9; 6-10,9; 11-14,9; and 15-18,9 years and males vs. females.

    2. Differences in Microvascular Flow Index (MFI) of sublingual microcirculation in different age and gender categories in children with T1D [baseline]

      Comparison in children aged 3-5,9; 6-10,9; 11-14,9; and 15-18,9 years and males vs. females.

    3. Differences in Small Vessel Density of sublingual microcirculation in different age and gender categories in children with T1D [baseline]

      Comparison in children aged 3-5,9; 6-10,9; 11-14,9; and 15-18,9 years and males vs. females.

    4. Differences Proportion of Perfused Vessels (all) of sublingual microcirculation in different age and gender categories in children with T1D [baseline]

      Comparison in children aged 3-5,9; 6-10,9; 11-14,9; and 15-18,9 years and males vs. females.

    5. Differences in Proportion of Perfused Small Vessels (PPSV) of sublingual microcirculation in different age and gender categories in children with T1D [baseline]

      Comparison in children aged 3-5,9; 6-10,9; 11-14,9; and 15-18,9 years and males vs. females.

    6. Differences in Perfused Vessel Density (PVD) of sublingual microcirculation in different age and gender categories in children with T1D [baseline]

      Comparison in children aged 3-5,9; 6-10,9; 11-14,9; and 15-18,9 years and males vs. females.

    7. Differences in Perfused Small Vessel Density (PSVD) of sublingual microcirculation in different age and gender categories in children with T1D [baseline]

      Comparison in children aged 3-5,9; 6-10,9; 11-14,9; and 15-18,9 years and males vs. females.

    8. Differences in DeBacker Score of sublingual microcirculation in different age and gender categories in children with T1D [baseline]

      Comparison in children aged 3-5,9; 6-10,9; 11-14,9; and 15-18,9 years and males vs. females.

    9. Correlation of Total Vascular Density of sublingual microcirculation with parameters of diabetic compenzation [baseline]

      Comparison of parametes in children with good and bad compenzation of T1D

    10. Correlation of Microvascular Flow Index (MFI) of sublingual microcirculation with parameters of diabetic compenzation [baseline]

      Comparison of parametes in children with good and bad compenzation of T1D

    11. Correlation of Small Vessel Density of sublingual microcirculation with parameters of diabetic compenzation [baseline]

      Comparison of parametes in children with good and bad compenzation of T1D

    12. Correlation of Proportion of Perfused Vessels (all) of sublingual microcirculation with parameters of diabetic compenzation [baseline]

      Comparison of parametes in children with good and bad compenzation of T1D

    13. Correlation of Proportion of Perfused Small Vessels (PPSV) of sublingual microcirculation with parameters of diabetic compenzation [baseline]

      Comparison of parametes in children with good and bad compenzation of T1D

    14. Correlation of Perfused Vessel Density (PVD) of sublingual microcirculation with parameters of diabetic compenzation [baseline]

      Comparison of parametes in children with good and bad compenzation of T1D

    15. Correlation of Perfused Small Vessel Density (PSVD) of sublingual microcirculation with parameters of diabetic compenzation [baseline]

      Comparison of parametes in children with good and bad compenzation of T1D

    16. Correlation of DeBacker Score of sublingual microcirculation with parameters of diabetic compenzation [baseline]

      Comparison of parametes in children with good and bad compenzation of T1D

    17. Differences of Total Vascular Density of sublingual microcirculation with parameters of healthy children in the same age categories [baseline]

      Total Vascular Density of sublingual microcirculation of healthy children has been obtained previously within study NCT05324228

    18. Differences of Microvascular Flow Index (MFI) of sublingual microcirculation with parameters of healthy children in the same age categories [baseline]

      Microvascular Flow Index (MFI) of sublingual microcirculation of healthy children has been obtained previously within study NCT05324228

    19. Differences of Small Vessel Density of sublingual microcirculation with parameters of healthy children in the same age categories [baseline]

      Small Vessel Density of sublingual microcirculation of healthy children has been obtained previously within study NCT05324228

    20. Differences of Proportion of Perfused Vessels (all) of sublingual microcirculation with parameters of healthy children in the same age categories [baseline]

      Proportion of Perfused Vessels (all) of sublingual microcirculation of healthy children has been obtained previously within study NCT05324228

    21. Differences of Proportion of Perfused Small Vessels (PPSV) of sublingual microcirculation with parameters of healthy children in the same age categories [baseline]

      Proportion of Perfused Small Vessels (PPSV) of sublingual microcirculation of healthy children has been obtained previously within study NCT05324228

    22. Differences of Perfused Vessel Density (PVD) of sublingual microcirculation with parameters of healthy children in the same age categories [baseline]

      Perfused Vessel Density (PVD) of sublingual microcirculation of healthy children has been obtained previously within study NCT05324228

    23. Differences of Perfused Small Vessel Density (PSVD) of sublingual microcirculation with parameters of healthy children in the same age categories [baseline]

      Perfused Small Vessel Density (PSVD) of sublingual microcirculation of healthy children has been obtained previously within study NCT05324228

    24. Differences of DeBacker Score of sublingual microcirculation with parameters of healthy children in the same age categories [baseline]

      DeBacker Score of sublingual microcirculation of healthy children has been obtained previously within study NCT05324228

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    3 Years to 18 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • type 1 diabetes mellitus

    • informed consent of parents

    Exclusion Criteria:
    • acute infection

    • period of metabolic decompensation and 14 days after it

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Masarykova Nemocnice v Usti nad Labem, Krajska Zdravotni a.s. Ústí Nad Labem Czechia

    Sponsors and Collaborators

    • Vlasta Krausová

    Investigators

    • Study Chair: David Neumann, MD, Ph.D., Hospital in Trutnov

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Vlasta Krausová, Principal Investigator, Masarykova Nemocnice v Usti nad Labem, Krajska Zdravotni a.s.
    ClinicalTrials.gov Identifier:
    NCT05958264
    Other Study ID Numbers:
    • 310/1
    First Posted:
    Jul 24, 2023
    Last Update Posted:
    Jul 24, 2023
    Last Verified:
    Jul 1, 2023
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Vlasta Krausová, Principal Investigator, Masarykova Nemocnice v Usti nad Labem, Krajska Zdravotni a.s.
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jul 24, 2023